trending Market Intelligence /marketintelligence/en/news-insights/trending/MzjN0wMviYjuV1lhs_VCJA2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Report: China's Harbin mulls takeover bid for GNC

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

Report: China's Harbin mulls takeover bid for GNC

China's Harbin Pharmaceutical Group Co. Ltd. is looking to acquire U.S. health and nutrition products retailer GNC Holdings Inc. and take the company private, Bloomberg News reported Oct. 22, citing people with knowledge of the matter.

Shares of Pittsburgh-based GNC jumped as much as 16.83% to $2.43 before closing up 10.10% to $2.29, while Harbin's stock rose as much as 1.32% in Shanghai to 3.83 Chinese yuan before closing up 0.79% to 3.81 yuan.

Harbin develops and manufactures pharmaceuticals in China and internationally. It is best known for its Hayao medicine brand, Bloomberg said.

The company has reportedly been in talks with potential advisers about an offer for GNC, but it has not made a final decision on whether to proceed.

Harbin is studying risks that could come from the deal including the possibility of regulatory scrutiny and the potential for GNC's business to further deteriorate, according to the report.

Bloomberg said representatives for Harbin did not immediately respond to requests for comment, while GNC declined to comment.

The Chinese company already holds a stake in GNC. In February, GNC secured $299.95 million in funding following a securities purchase agreement with Harbin.

The potential offer comes as GNC is looking at a range of refinancing options, which the company plans to complete by 2019-end, one of the sources told the news outlet.

Back in July, following the release of GNC's second-quarter earnings, CEO Ken Martindale told an investor presentation that the company is looking to close up to 900 stores as part of its 2019 and 2020 cost savings targets.

As of Oct. 22, US$1 was equivalent to 7.08 Chinese yuan.